Dr. Neelima Denduluri completed her Hematology/Oncology fellowship at the National Cancer Institute in Bethesda, Maryland, where she served as Chief Fellow. She received her Doctorate of Medicine at Louisiana State University Medical Center and completed her Internal Medicine Residency at Georgetown University Medical Center in Washington, D.C. Dr. Denduluri has been involved in teaching at Georgetown, the National Naval Medical Center and National Cancer Institute.
During Dr. Denduluri's time at the NIH, she served as a protocol chair and associate investigator on many trials. Dr. Denduluri has also published multiple articles and abstracts that have been in ASCO Educational Books, the Journal of Clinical Oncology and Clinical Breast Cancer among others. Her work has been presented at the American Society of Clinical Oncology and the San Antonio Breast Cancer Symposium.
Dr. Denduluri was awarded the Exemplar of Desirable Attitudes of the Physician Toward His Patients upon graduation for Louisiana State University during her training.
 Hospital in the News
Doctor Discusses Fears Over Chemo After Roberts' MDS Announcement
Jun 13, 2012
WASHINGTON (WUSA) -- Good Morning America co-anchor Robin Roberts has started pre-treatment for MDS. It's a disease of the bone and blood marrow.
When she made the announcement Monday, Roberts said the illness was a direct result of the chemo therapy she received 5-years ago to fight her breast cancer. Should other women getting chemo be worried about a similar diagnosis?
On Wednesday morning, Doctor Neelima Denduluri, an oncologist at the Virginia Hospital Center in Arlington, talked about whether the fears are valid, how rare the MDS diagnosis is and whether breast cancer patients are being informed about the possible side effect.
Click here to view the segment.
 Congratulations to Dr. Nelima Denduluri for being named in Northern Virginia Magazine’s 2013 TOP DOCTORS! |